OracleBio Webinar: Using Artificial Intelligence to support Quantitative Digital Pathology in R&D
Using Artificial Intelligence to support Quantitative Digital Pathology in R&D
DATE & TIME
Wednesday 17th November @ 4:00pm GMT / 11:00am EST / 8:00am PST
What you’ll learn:
This free session will be presented by OracleBio’s Chief Scientific Officer, Lorcan Sherry, and will cover:
- Using AI Deep Learning to improve image analysis accuracy and turn-around time in a pre-clinical tumor IHC study
- Integrating clinical pathologist input in development and validation of a Deep Learning Tissue Classifier App
- Advantages of implementing Deep Learning for tissue segmentation and cell detection in multiplex IF studies
- and more…
About the Presenter
Lorcan Sherry is an image analysis expert who previously spent 10 years in the pharmaceutical industry as a group leader (Organon, Schering-Plough, Merck & Co.). He led a group responsible for performing histology, immunohistochemistry / image analysis and he has considerable experience in developing translational biomarker strategies for projects across various therapeutic areas.
As co-founder and Chief Scientific Officer at OracleBio, Lorcan has helped establish the company as a market leader within its field, supporting the digital pathology programmes of major Pharma and Biotech companies around the globe. Day to day, Lorcan oversees a team of image analysis scientists and pathologists responsible for the execution of Client image analysis R&D studies, while further driving the adoption of innovative techniques and processes to improve the quality and efficiency of our services.
